Jun 2026 (Q2 FY26) — Aug 7, 2026
Nutex Health Q2 FY26 — Strong Financials and IDR Process Improvements Drive Growth
Read the full callNutex Health (NUTX) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Nutex Health earnings: last reported Fri, 7 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 211 | −13.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 57.8 | +44.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 65.8 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$191.25 +2.77% · +$5.15
Performance +101.7% 1Y
1Y: $94.84 on 17 Oct 2025 → $191.25. High $225 (5 Oct 2026), low $87.01 (12 Mar 2026).
- Previous close
- $186.1
- 52-week range
- $87.01 – $225
- One year
- +72.30%
Overview
- Symbol
- NUTX
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Nutex Health earnings calls (NUTX)
Financials
What the filings say
Net profit, year on year: +472% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 79 | 258 | 212 | 244 | 268 | 152 | 216 | 211 |
| Expenses | 57 | 116 | 93 | 119 | 113 | 106 | 125 | 69 |
| Operating profit | 10 | 114 | 81 | 34 | 130 | 31 | 81 | 122 |
| Operating margin | 12.3% | 44.3% | 38.1% | 13.8% | 48.7% | 20.4% | 37.5% | 57.8% |
| Interest | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 5 |
| Profit before tax | -3 | 109 | 71 | 24 | 124 | 26 | 77 | 117 |
| Tax rate | −177.7% | 7.9% | 28.7% | 32.0% | 21.9% | 35.9% | 18.0% | 17.7% |
| Net profit | -9 | 62 | 21 | -18 | 55 | 12 | 47 | 66 |
| EPS ($ per share) | -1.72 | 11.83 | 3.74 | -2.95 | 8.27 | — | 6.70 | 9.58 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -5 | -13 | -18 | 102 | -363 | -409 | -357 | -286 |
| Total liabilities | 2 | 5 | 1 | 203 | 311 | 319 | 467 | 495 |
| Fixed assets | 0 | 0 | 0 | 152 | 82 | 81 | 78 | 95 |
| Total assets | 0 | 7 | 0 | 395 | 432 | 398 | 655 | 919 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -0 | -4 | 87 | 173 | 51 | 1 | 23 | 248 |
| Cash from investing | -0 | -1 | -61 | -37 | -4 | -11 | -6 | -5 |
| Cash from financing | 1 | 6 | -8 | -126 | -48 | -2 | 1 | -98 |
| Capital expenditure | 0 | -0 | -61 | -37 | -15 | -9 | -2 | -3 |
| Free cash flow | -0 | -4 | 25 | 137 | 36 | -8 | 21 | 246 |
Insider filings
26 filings between Nov 25, 2025 and Sep 18, 2026.
Open market
decisions to buy or sellPurchases
$148.2K
5 purchases by 5 insiders
Sales
$43.5K
1 sale by 1 insider
Compensation
not trading decisions- 11
- Option exercise — converted options into shares
- 6
- Tax withheld — shares kept back by the company to cover tax
Also filed: 3 other filings.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Bates Jon Christian | $102.5K | — | Nov 25, 2025 |
| Saunders Scott J | — | $43.5K | Sep 18, 2026 |
| Hosseinion Warren | $23.7K | — | Mar 19, 2026 |
| Jaumot Frank E | $14.0K | — | Mar 20, 2026 |
| Montgomery Pamela W. | $7.0K | — | Mar 13, 2026 |
| Spears Kelvin | $945 | — | Mar 17, 2026 |
Latest filings (46)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Saunders Scott J Director | Sale | 203 | $43.5K |
| Jul 31, 2026 | Saunders Scott J Director | Option exercise | 603 | $0 |
| Jul 31, 2026 | Jaumot Frank E Director | Option exercise | 603 | $0 |
| Jul 31, 2026 | Grenas Cheryl Yvonne Director | Option exercise | 603 | $0 |
| Jul 31, 2026 | Reed Michael Lee Director | Option exercise | 603 | $0 |
| Jun 4, 2026 | Spears Kelvin Director | Other | 2,519 | $0 |
| May 28, 2026 | Vo Thomas T. Chief Executive Officer | Other | 75,747 | $0 |
| Apr 9, 2026 | Vo Thomas T. Chief Executive Officer | Other | 184,071 | $0 |
| Mar 20, 2026 | Jaumot Frank E Director | Purchase | 150 | $14.0K |
| Mar 19, 2026 | Hosseinion Warren President | Purchase | 252 | $23.7K |
| Mar 17, 2026 | Spears Kelvin Director | Purchase | 10 | $945 |
| Mar 13, 2026 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Purchase | 79 | $7.0K |
| Mar 10, 2026 | Spears Kelvin Director | Tax withheld | 82 | $7.1K |
| Mar 10, 2026 | Chang Michael L. Chief Medical Officer | Tax withheld | 769 | $66.3K |
| Mar 10, 2026 | Hosseinion Warren President | Option exercise | 6,293 | $0 |
| Mar 10, 2026 | Hosseinion Warren President | Tax withheld | 3,274 | $282.3K |
| Mar 10, 2026 | Luqman Elisa V Chief Legal Officer - SEC | Option exercise | 2,084 | $0 |
| Mar 10, 2026 | Luqman Elisa V Chief Legal Officer - SEC | Tax withheld | 784 | $67.6K |
| Mar 10, 2026 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Option exercise | 2,084 | $0 |
| Mar 10, 2026 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Tax withheld | 776 | $66.9K |
| Mar 10, 2026 | Chang Michael L. Chief Medical Officer | Option exercise | 2,084 | $0 |
| Mar 10, 2026 | Vo Thomas T. Chief Executive Officer | Option exercise | 8,334 | $0 |
| Mar 10, 2026 | Vo Thomas T. Chief Executive Officer | Tax withheld | 3,017 | $260.1K |
| Mar 10, 2026 | Bates Jon Christian Chief Financial Officer | Option exercise | 2,667 | $0 |
| Mar 10, 2026 | Spears Kelvin Director | Option exercise | 183 | $0 |
| Nov 25, 2025 | Bates Jon Christian Chief Financial Officer | Purchase | 750 | $102.5K |
| Apr 8, 2025 | Bates Jon Christian Chief Financial Officer | Purchase | 1,000 | $81.8K |
| Apr 4, 2025 | Hosseinion Warren President | Tax withheld | 1,072 | $77.3K |
| Apr 4, 2025 | DeTillio Joshua Chief Operating Officer | Tax withheld | 452 | $32.6K |
| Apr 4, 2025 | Chang Michael L. Chief Medical Officer | Tax withheld | 266 | $19.2K |
| Apr 4, 2025 | Vo Thomas T. Chief Executive Officer | Tax withheld | 895 | $64.5K |
| Apr 4, 2025 | Luqman Elisa V Chief Legal Officer - SEC | Tax withheld | 266 | $19.2K |
| Apr 4, 2025 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Tax withheld | 24 | $1.7K |
| Apr 4, 2025 | Spears Kelvin Director | Tax withheld | 34 | $2.5K |
| Apr 4, 2025 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Tax withheld | 266 | $19.2K |
| Mar 1, 2025 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Option exercise | 1,250 | $0 |
| Mar 1, 2025 | Hosseinion Warren President | Option exercise | 3,776 | $0 |
| Mar 1, 2025 | Vo Thomas T. Chief Executive Officer | Option exercise | 5,000 | $0 |
| Mar 1, 2025 | Chang Michael L. Chief Medical Officer | Option exercise | 1,250 | $0 |
| Mar 1, 2025 | Montgomery Pamela W. Chief Legal Officer-Healthcare | Option exercise | 111 | $0 |
| Mar 1, 2025 | Luqman Elisa V Chief Legal Officer - SEC | Option exercise | 1,250 | $0 |
| Mar 1, 2025 | DeTillio Joshua Chief Operating Officer | Option exercise | 2,125 | $0 |
| Mar 1, 2025 | Spears Kelvin Director | Option exercise | 143 | $0 |
| Mar 1, 2025 | Bates Jon Christian Chief Financial Officer | Option exercise | 111 | $0 |
| Mar 1, 2025 | Bates Jon Christian Chief Financial Officer | Option exercise | 1,500 | $0 |
| Jan 8, 2025 | Vo Thomas T. Chief Executive Officer | Gift | 5,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Nutex Health Inc.
Free account. Everything above stays public.
Write why you follow Nutex Health Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading